The US FDA has approved Pfizer’s vaccine Penbraya for ages 10 to 25, offering protection against the five main types of bacteria causing meningitis and blood poisoning. As a two-dose vaccine administered six months apart, it combines elements of Trumenba and Menveo and reduces the current four-dose regimen for full protection. The CDC will discuss recommendations for Penbraya’s use in adolescents and young adults.
Linux Creator Linus Torvalds Rejects Anti-AI Push and Defends LLM Tools
Linux creator and top-level kernel maintainer Linus Torvalds has made it clear that the Linux kernel project will not adopt an anti-AI stance. He believes
